US Government to Repatriate Kennewick Man

A 2015 ancient DNA study determined that the 8,500-year-old skeletal remains belonged to an individual of Native American ancestry. Now, the US Army Corp of Engineers has begun the process of returning the bones to their rightful owners.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Kennewick Man, Chip ClarkIMAGE: CHIP CLARK/SMITHSONIAN INSTITUTIONLast year, an international team used ancient DNA technology to determine that the 8,500-year-old “Kennewick Man” skeleton was Native American. Researchers at the University of Chicago independently verified the finding earlier this month. And now, the US government has made it official: the Army Corp of Engineers, after reviewing the data on Kennewick Man, has declared that the remains—which it currently owns—are in fact of Native American origin. “I find that there is substantial evidence to determine that Kennewick Man is related to modern Native Americans from the United States,” Army Brigadier General Scott Spellmon, commander of the Army Corps’ Northwestern Division, said in a report released this week (April 26).

The official statement paves the way for Native American tribes to reclaim and bury the remains, which scientists discovered on Army Corp land along the Columbia River in Washington in 1996. Since their unearthing, the remains have served as the focal point for a litany of legal filings—suits filed against the Army Corp by researchers seeking to study the bones and similar legal claims made by Native American tribes trying to obtain Kennewick Man. And previous anthropolocial research suggested that Kennewick Man may have been of Asian or Caucasian extraction. “Obviously we are hearing an acknowledgment from the Corps of what we have been saying for 20 years,” JoDe Goudy, chairman of the Yakama Nation, told The Seattle Times. “Now we want to collectively do ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies